Re:New antibody attacks 99% of HIV strains
by chasil on Friday September 22, 2017 @03:34PM
(#15315072)
Antibody manufacture is not cheap. The antibodies are made by fusing the b-memory cells with mouse cancer, then putting the result in a bioreactor and filtering out the desired product, which must then be refrigerated. Drugs that use this technique commonly end in -MAB (for monoclonal antibody).
[ Parent
| on HN ]
Re:New antibody attacks 99% of HIV strains
by L_Rahman on Saturday September 23, 2017 @01:01PM
(#15320604)
Given the entrenched nature of the American pharmaceutical industry, I'm unconvinced that any of them have actually tried to solve the problem of cheap antibody manufacturing at scale.
Re:New antibody attacks 99% of HIV strains
by refurb on Sunday September 24, 2017 @12:19AM
(#15323278)
Why wouldn't they? Any reduction in cost is pure profit for them.
Re:New antibody attacks 99% of HIV strains
by Kalium on Monday September 25, 2017 @12:23PM
(#15331708)
Reflexive paranoia rather than calm business analysis tends to rule the day when pharmaceutical companies are under consideration.
Re:New antibody attacks 99% of HIV strains
by danielmorozoff on Friday September 22, 2017 @03:49PM
(#15315191)
Are these monoclonals or polys? Does anyone have a paper ref?